This is generally a long-term treatment solution, and there are precise instructions that you need to follow if you want to see improvements in your diabetes management
Peptidyl and non-peptidyl oral glucagon-like peptide-1 receptor agonists
Short-acting formulations reach peak plasma concentrations within 1-3.5 hours and have shorter elimination half-lives, while long-acting agents like semaglutide have half-lives of approximately one week, allowing for sustained therapeutic effects
Diabetes (2018) 67(11):215766
You deserve a good nights sleep, no matter what medication youre taking
While the research we have is mixed, and this clearly shows it in this Harvard study, I believe that if there's any possibility of risk of increasing neurodevelopmental disorders in our children while pregnant or while they're young, we deserve to know about that